New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

byRegenstrief InstituteCredit: Unsplash/CC0 Public DomainManaging symptoms improves quality of life. Sleep disturbance, pain, physical function impairment, anxiety, depression, and low energy/fa
World medicine December 04,2023
Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

Study assesses prevalence, severity, co-occurrence of common symptoms undertreated in cancer patients

byRegenstrief InstituteCredit: Unsplash/CC0 Public DomainManaging symptoms improves quality of life. Sleep disturbance, pain, physical function impairment, anxiety, depression, and low energy/fa
World medicine December 04,2023
Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

by The GOG Foundation IncCredit: Pixabay/CC0 Public DomainThe GOG Foundation, Inc. (GOG) announced positive results from an investigator-initiated phase II trial, sponsored by the GOG, investigating t
World medicine December 04,2023
Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

Positive results for combination of ribociclib and letrozole in patients with recurrent low-grade serous ovarian cancer

by The GOG Foundation IncCredit: Pixabay/CC0 Public DomainThe GOG Foundation, Inc. (GOG) announced positive results from an investigator-initiated phase II trial, sponsored by the GOG, investigating t
World medicine December 04,2023
A cancer-wide analysis finds cancer-wide targets for tumor reduction

A cancer-wide analysis finds cancer-wide targets for tumor reduction

by Justin Jackson , Medical Xpress\Cell line expression of tumor-specific TE-chimeric transcripts. a, Box plots with overlaid dot plots of the number of candidates expressed in each cancer cell line p
World medicine December 04,2023
A cancer-wide analysis finds cancer-wide targets for tumor reduction

A cancer-wide analysis finds cancer-wide targets for tumor reduction

by Justin Jackson , Medical Xpress\Cell line expression of tumor-specific TE-chimeric transcripts. a, Box plots with overlaid dot plots of the number of candidates expressed in each cancer cell line p
World medicine December 04,2023
Certain exosomes found to inhibit malignant melanoma growth, providing important prognostic marker

Certain exosomes found to inhibit malignant melanoma growth, providing important prognostic marker

byOsaka Metropolitan UniversityOsaka Metropolitan University researchers have found that exosomes, a type of small vesicle, produced by cancer-associated fibroblasts (CAFs) play an important rol
World medicine December 04,2023
Certain exosomes found to inhibit malignant melanoma growth, providing important prognostic marker

Certain exosomes found to inhibit malignant melanoma growth, providing important prognostic marker

byOsaka Metropolitan UniversityOsaka Metropolitan University researchers have found that exosomes, a type of small vesicle, produced by cancer-associated fibroblasts (CAFs) play an important rol
World medicine December 04,2023
Healthy lifestyle associated with reduced mortality risk in childhood cancer survivors

Healthy lifestyle associated with reduced mortality risk in childhood cancer survivors

bySt. Jude Children's Research Hospital(L to R) Co-author Yutaka Yasui, Ph.D., and senior author Greg Armstrong, M.D., M.S.C.E., both of St. Jude Department of Epidemiology and Cancer Contro
World medicine December 04,2023
Healthy lifestyle associated with reduced mortality risk in childhood cancer survivors

Healthy lifestyle associated with reduced mortality risk in childhood cancer survivors

bySt. Jude Children's Research Hospital(L to R) Co-author Yutaka Yasui, Ph.D., and senior author Greg Armstrong, M.D., M.S.C.E., both of St. Jude Department of Epidemiology and Cancer Contro
World medicine December 04,2023
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy

Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy

byInstitute of Cancer ResearchProstate tumour biopsy sample from a patient showing areas with ‘normal’ PTEN protein (brown stained regions) and areas with loss of PTEN protein (blue unstained re
World medicine December 04,2023
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy

Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy

byInstitute of Cancer ResearchProstate tumour biopsy sample from a patient showing areas with ‘normal’ PTEN protein (brown stained regions) and areas with loss of PTEN protein (blue unstained re
World medicine December 04,2023
Implantable oxygen-eating batteries help kill cancer

Implantable oxygen-eating batteries help kill cancer

by Peter Grad , Medical XpressThe rationale of the self-charging battery for tumor therapy. (A) Positive electrode material of the battery in the discharging mode is able to effectively reduce the oxy
World medicine December 04,2023
Implantable oxygen-eating batteries help kill cancer

Implantable oxygen-eating batteries help kill cancer

by Peter Grad , Medical XpressThe rationale of the self-charging battery for tumor therapy. (A) Positive electrode material of the battery in the discharging mode is able to effectively reduce the oxy
World medicine December 04,2023
Breakthrough CAR-T cancer treatments are boosting patients' quality of life

Breakthrough CAR-T cancer treatments are boosting patients' quality of life

by Amy NortonA therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.The treatment, calledchimeric antigen receptor(C
World medicine December 04,2023
Breakthrough CAR-T cancer treatments are boosting patients' quality of life

Breakthrough CAR-T cancer treatments are boosting patients' quality of life

by Amy NortonA therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds.The treatment, calledchimeric antigen receptor(C
World medicine December 04,2023
Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer

Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainNRG Oncology GOG-0240 is the phase 3 randomized trial that demonstrated that the incorporation of bevacizumab with chemotherapy resulted in a statistic
World medicine December 04,2023
Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer

Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer

by NRG OncologyCredit: Unsplash/CC0 Public DomainNRG Oncology GOG-0240 is the phase 3 randomized trial that demonstrated that the incorporation of bevacizumab with chemotherapy resulted in a statistic
World medicine December 04,2023
2019 to 2021 saw rise in lung cancer screenings

2019 to 2021 saw rise in lung cancer screenings

by Lori SolomonThe prevalence of lung cancer screening (LCS) increased in 2021 versus 2019, according to a research letter published online June 21 inJAMA Network Open.Kristin G. Maki, Ph.D., fr
World medicine December 04,2023
2019 to 2021 saw rise in lung cancer screenings

2019 to 2021 saw rise in lung cancer screenings

by Lori SolomonThe prevalence of lung cancer screening (LCS) increased in 2021 versus 2019, according to a research letter published online June 21 inJAMA Network Open.Kristin G. Maki, Ph.D., fr
World medicine December 04,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com